Bovine Colostrum Supplementation in Athletes
NCT06123910
Innate Immunity
Hermosillo, Sonora, Mexico
View Trial DetailsNCT Number: NCT03639376
This study investigates the salivary LL-37 in passive smoking-exposed and unexposed children and the association between salivary LL-37 levels and periodontal clinical parameters in these children.Unstimulated salivary samples were collected from 180 children (90 passive smoking-exposed and 90 passive smoking-unexposed)
Looking for future studies?
Notify Me6 year–12 year
All sexes
Observational
Diverse mechanisms conduce to the detrimental periodontal effects of passive smoking, including alteration of both microbial and host response factors.
Antimicrobial peptides are considered to be an important intermediate step in initiating an initial immune response against the microbial side of the oral gingival epithelium and in the transition to acquired immunity.
LL-37 has a wide antimicrobial activity against both cariogenic and periopathogenic bacteria and its role in maintaining oral health has recently been stated
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: In the first 18 months of study
LL-37 (pg/mL)
Time frame: In the first 18 months of study
Cotinine (ng/mL)
Kırıkkale University
Other
Salivary LL-37 and Periodontal Health in Children Exposed to Passive Smoking
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06123910
Innate Immunity
Hermosillo, Sonora, Mexico
View Trial DetailsNCT03886350
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Tours, France
View Trial DetailsNCT02953327
Bacille Calmette-Guérin, Innate Immunity
Bissau, Bissau Codex, Guinea-Bissau
View Trial DetailsNCT01386489
Adaptive Immunity, HIV Negative
Bethesda, Maryland, United States
View Trial Details